MedTrace Logo

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

NCT07143669 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2026-05-22

No results posted yet for this study

Summary

This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease.

Conditions

  • Clonal Mast Cell Disease
  • KIT D816V Mutation
  • Suspected KITD816V Mutated Clonal Mast Cell Disease

Interventions

OTHER

Screening

After providing informed consent and relevant medical history data, samples will be collected from participants with suspected clonal mast cell disease.

Sponsors & Collaborators

  • Blueprint Medicines Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-17
Primary Completion
2028-07-31
Completion
2028-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07143669 on ClinicalTrials.gov